Results 131 to 140 of about 1,131,539 (313)

TFF-1 Functions to Suppress Multiple Phenotypes Associated with Lung Cancer Progression

, 2021
Katsuyuki Minegishi, Yoh Dobashi, Hiroyoshi Tsubochi, Koichi Hagiwara, Yuko Ishibashi, Sachiyo Nomura, Rieko Nakamura, Yasukazu Ohmoto, Satoshi Endo   +8 more
openalex   +1 more source

Case study of ventilatory function of lung cancer, bronchial asthma, chronic bronchitis and lung emphysema -Case Report- [PDF]

, 1974
Sang Baik Oh, Jie Han
openalex   +1 more source

Influence of body mass index and age on the lung function of obese women

, 2022
Dayla Sgariboldi, Fernanda Aparecida Faria, Jéssica Cristina Carbinatto, Eli Maria Pazzianotto‐Forti   +3 more
openalex   +1 more source

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

Molecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga, María Luz Martinez‐Chantar, Carolina Conter   +2 more
wiley   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Visit-to-visit glycemic variability is associated with lung function variables and lung function impairment in individuals with type 2 diabetes. [PDF]

PLoS One
Wu YH, Li CI, Liu CS, Lin CH, Yang SY, Lin CC, Li TC.   +6 more
europepmc   +1 more source

Lung-function Tests [PDF]

BMJ, 1964
openaire   +2 more sources

Lactoferrin treatment activates acetylcholinesterase, decreasing acetylcholine levels in non‐small cell lung cancer (NSCLC) cell culture supernatants, inhibiting cell survival

FEBS Open Bio, EarlyView.
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel, Caroline Wozniak, Aya Sabri, Ben Haddad, Brooke Lopo, Alvaro Cobos, Sarah Sarofim, Jeffrey Guthrie, Deborah Heyl, Hedeel Guy Evans   +9 more
wiley   +1 more source

Does Excluding Participants Improve Our Understanding of Lung Function? [PDF]

Am J Respir Crit Care Med
Baugh AD, Campbell J.
europepmc   +1 more source

Indoleamine 2,3‐dioxygenase 1 inhibition reverses cancer‐associated fibroblast‐mediated immunosuppression in high‐grade serous ovarian cancer

FEBS Open Bio, EarlyView.
CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee, Jung Yoon Ho, In Sun Hwang, Youn Jin Choi   +3 more
wiley   +1 more source